Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
63 Cards in this Set
- Front
- Back
mechanism of heparin?
|
catalyzes the activation of antithrombin III, decreases thrombin and Xa
|
|
which can be used during pregnancy - heparin or warfarin?
|
heparin
|
|
what drug can be used for rapid reversal of heparin?
How does it work? |
protamine sulfate - positively charged molecule that acts by binding negatively charged heparin
|
|
what lab values do you monitor with heparin use?
|
PTT
|
|
mechanism of warfarin?
|
interferes with normal synthesis and gamma-carboxylation of vitamin K-dependent clotting factors II, VII, IX, and X and proteins C and S
|
|
what pathway does warfarin affect?
|
extrinsic - increases PT
|
|
how do you reverse warfarin?
|
vitamin K of FFP
|
|
what labs do you follow with warfarin use?
|
PT or INR
|
|
onset of action of heparin? warfarin?
|
heparin - fast
warfarin - slow (limited by half-lives of vitamin K-dependent clotting factors) |
|
how do thrombolytics work?
|
directly or indirectly aid conversion of plasminogen to plasmin, the major fibrinolytic enzyme, which cleaves thrombin and fibrin clots
|
|
What is the toxicity of thrombolytic therapy?
how do you treat tPA toxicity? |
aminocaproic acid, an inhibitor of fibrinolysis
|
|
mechanism of aspirin?
|
acetylates and irreversibly inhibits cyclooxygenase to prevent conversion of arachidonic acid to prostaglandins
|
|
how does aspirin affect bleeding time, PT, PTT
|
increases bleeding time, no effect on PT or PTT
|
|
these inhibit platelet aggregation by irreversibly blocking ADP receptors; inhibit fibrinogen binding by preventing glycoprotein IIb/IIIa expression
|
clopidogrel, ticlopidine
|
|
toxicity of ticlopidine?
|
neutropenia
|
|
What is the mechanism of action of Abciximab?
|
monoclonal antibody that binds to the glycoprotein receptor IIb/IIIa on activated platelets, preventing aggregation
|
|
methotrexate mechanism?
|
folic acid analog that inhibits dihydrofolate reductase, resulting in decreased dTMP and therefore decreased DNA and protein synthesis
S-phase specific |
|
toxicity of methotrexate? what can reverse it?
|
myelosuppression - leucovorin (folinic acid) rescue
|
|
this is an S-phase specific antimetabolite
|
5-FU + methotrexate
|
|
5-fluorouracil
|
pyrimidine analog bioactivated to 5F-dUMP, which covalently complexes folic acid - this complex inhibits thymidylate synthase, resulting in decreaed dTMP and inhibition of DNA synthesis
|
|
toxicity of 5-FU?
|
myelosupression - not reversible with leucovorin
|
|
blocks de novo purine synthesis; activated by HGPRTase
|
6-mercaptopurine
|
|
cancer drug that is metabolized by xanthine oxidase
|
6-mercaptopurine - thus increased toxicity with allopurinol
|
|
inhibits DNA polymerase; used in AML
|
cytarabine
|
|
alkylating agents that covalently x-link (interstrand) DNA at guanine N-7
|
cyclophosphamide, ifosfamide
|
|
What is the major toxicity of cyclophosphamide and ifosfamide?
How is it prevented? |
hemorrhagic cystitis; mesna offers partial prevention
|
|
carmustine, lomustine, semustine, and streptozocin are what kind of drug?
|
nitrosureas
|
|
clinical use of nitrosureas?
|
brain tumors
|
|
mechanism of nitrosureas?
|
alkylate DNA; require bioactivation
|
|
these drugs act like alkylating agents and are used for testicular, bladder, ovary, and lung carcinomas
|
cisplatin, carboplatin
|
|
drug that alkylates DNA and is used for CML
|
busulfan
|
|
toxicity of busulfan?
|
pulmonary fibrosis, hyperpigmentation
|
|
drugs that generate free radicals and noncovalently intercalate in DNA (creating breaks in DNA strand to reduce replication)
|
doxorubicin, daunorubicin
|
|
toxicity of doxorubicin, daunorubicin
|
cardiotoxicity; myelosuppression and marked alopecia
|
|
drug used for Wilms' tumor, Ewing's sarcoma, rhabdomyosarcoma?
|
dactinomycin (actinomycin D) - used for childhood tumors - children ACT out
|
|
toxicity of bleomycin?
|
pulmonary fibrosis, skin changes, but minimal myelosuppression
|
|
toxicity of vincristine?
|
neurotoxicity (areflexia, peripheral neuritis), paralytic ileus
|
|
toxicity of vinblastine?
|
vinBLASTine BLASTs bone marrow (suppression)
|
|
what is the most commonly used glucocorticoid used in cancer chemo?
|
prednisone
|
|
monoclonal antibody against HER-2 (erb-B2)
|
trastuzumab (Herceptin)
|
|
M-phase-specific alkaloids that bind to tubulin and block polymerization of microtubules so that mitotic spindle cannot form
|
vincristine, vinblastine - arrest cell at metaphase
|
|
estrogen receptor mixed agonist/antagonists that block the binding of estrogen to estrogen receptor-positive cells
|
tamoxifen, raloxifene
|
|
G2-phase-specific agent that inhibits topoisomerase II and increases DNA degradation
|
etoposide
|
|
monoclonal antibody agains the Philadelphia chromosome bcr-abl tyrosine kinase
|
imatinib (Gleevec)
|
|
What is the toxicity of warfarin?
|
bleeding, teratogenic, drug/drug interactions
|
|
What is used for short term anti-coagulation? Long term?
|
Heparin - short
Warfarin - Long |
|
What lab changes are expected with thrombolytic use?
|
increased PT and PTT
|
|
What are the major toxicities of aspirin
|
gastric ulceration, bleeding, tinnitus (CNVIII), Reye's syndrome
|
|
What happens with acute aspirin toxicity?
|
initial respiratory alkalosis that depletes bicarb buffering capacity. Then ASA crosses BBB and induces metabolic acidosis and directly inhibits breathing to cause respiratory acidosis.
|
|
Abciximab toxicity?
|
bleeding, thrombocytopenia
|
|
Cisplatin, carboplatin toxicity?
|
nephrotoxicity and acoustic nerve damage
|
|
mechanism of dactinomycin?
|
intercalates in DNA
|
|
toxicity of dactinomycin?
|
myelosuppression
|
|
mechanism of bleomycin?
|
induces formation of free radicals, which cause breaks in DNA strands
|
|
mechanism of hydroxyurea?
|
inhibits Ribonucleotide reductase --> decreases DNA synthesis (S-phase specific)
|
|
toxicity of hydroxyuria?
|
bone marrow suppression, GI upset
|
|
Toxicity of Etoposide (VP-16)?
|
myelosuppression, GI irritation, alopecia
|
|
toxicity of prednisone?
|
cushing-like symptoms
|
|
toxicity of Tamoxifen and raloxifene?
|
tamoxifen: increased risk of endometrial carcinoma
Raloxifene: endometrial antagonist so no increase in endometrial carcinoma |
|
toxicity of Trastuzumab (Herceptin)?
|
cardiotoxicity
|
|
toxicity of Imatinib (Gleevec)
|
fluid retention
|
|
mechanism of Paclitaxel?
|
M-phase-specific. binds to tubulin and hyperstabilize polymerized microtubules so that mitotic spindle cannot break down. --> arrests in metaphase
|
|
toxicity of paclitaxel
|
myelosuppression and hypersensitivity
|